FDA Announces Michelle Tarver, M.D., Ph.D., as Director of the FDA’s Center for Devices and Radiological Health

On Oct. 22, the FDA announced that Michelle Tarver, M.D., Ph.D., has been selected as the permanent director of the FDA’s Center for Devices and Radiological Health (CDRH). Dr. Tarver is a board-certified ophthalmologist with a doctorate in epidemiology and has held various leadership positions at the FDA as a medical device regulator, helping drive strategic initiatives, conduct clinical research and changing organizational culture. Under her leadership, CDRH launched numerous efforts to amplify the perspectives of people living with medical conditions, foster collaboration across the health care ecosystem and stimulate creative evidence generation pathways. 

Michelle Tarver, M.D., Ph.D., director of the FDA’s CDRH issued the following statement:

“I am truly honored to lead CDRH and our talented staff across the Center who are committed to protecting and promoting public health. As someone who has served the FDA for more than 15 years, I am immensely proud of the work we have accomplished together, always keeping the people we serve at the core of our mission. As we embark on CDRH’s next chapter, we remain committed in our service to public health and ensuring all patients in the U.S. have access to high-quality, safe and effective medical devices.”